283 related articles for article (PubMed ID: 22219179)
1. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.
Montales MT; Rahal OM; Kang J; Rogers TJ; Prior RL; Wu X; Simmen RC
Carcinogenesis; 2012 Mar; 33(3):652-60. PubMed ID: 22219179
[TBL] [Abstract][Full Text] [Related]
2. Repression of mammary adipogenesis by genistein limits mammosphere formation of human MCF-7 cells.
Montales MT; Rahal OM; Nakatani H; Matsuda T; Simmen RC
J Endocrinol; 2013 Jul; 218(1):135-49. PubMed ID: 23645249
[TBL] [Abstract][Full Text] [Related]
3. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN.
Dave B; Eason RR; Till SR; Geng Y; Velarde MC; Badger TM; Simmen RC
Carcinogenesis; 2005 Oct; 26(10):1793-803. PubMed ID: 15905199
[TBL] [Abstract][Full Text] [Related]
4. PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation.
Rahal OM; Simmen RC
Carcinogenesis; 2010 Aug; 31(8):1491-500. PubMed ID: 20554748
[TBL] [Abstract][Full Text] [Related]
5. [Influence factors on the formation of mammospheres from breast cancer stem cells].
Huang MZ; Zhang FC; Zhang YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
[TBL] [Abstract][Full Text] [Related]
6. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
7. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
[TBL] [Abstract][Full Text] [Related]
8. [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
Lu ZH; Jia J; Ren J; Ma B; DI LJ; Song GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):480-5. PubMed ID: 18931709
[TBL] [Abstract][Full Text] [Related]
9. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
Li Z; Liu CP; He YL; Tian Y; Huang T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones increase latency of spontaneous mammary tumors in mice.
Jin Z; MacDonald RS
J Nutr; 2002 Oct; 132(10):3186-90. PubMed ID: 12368416
[TBL] [Abstract][Full Text] [Related]
12. Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation.
Vuong T; Mallet JF; Ouzounova M; Rahbar S; Hernandez-Vargas H; Herceg Z; Matar C
J Transl Med; 2016 Jan; 14():13. PubMed ID: 26762586
[TBL] [Abstract][Full Text] [Related]
13. Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.
Hewitt AL; Singletary KW
Cancer Lett; 2003 Mar; 192(2):133-43. PubMed ID: 12668277
[TBL] [Abstract][Full Text] [Related]
14. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner.
Allred CD; Allred KF; Ju YH; Virant SM; Helferich WG
Cancer Res; 2001 Jul; 61(13):5045-50. PubMed ID: 11431339
[TBL] [Abstract][Full Text] [Related]
15. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
16. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
[TBL] [Abstract][Full Text] [Related]
17. Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagy.
Yenigun VB; Ozpolat B; Kose GT
Int J Mol Med; 2013 Jun; 31(6):1477-83. PubMed ID: 23589132
[TBL] [Abstract][Full Text] [Related]
18. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
19. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA
Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531
[TBL] [Abstract][Full Text] [Related]
20. Enhanced mammary progesterone receptor-A isoform activity in the promotion of mammary tumor progression by dietary soy in rats.
Dave B; Wynne R; Su Y; Korourian S; Chang JC; Simmen RC
Nutr Cancer; 2010; 62(6):774-82. PubMed ID: 20661826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
